Wen Xie, MD
Transplant Surgery · Pensacola, FLNPI 1508438250
Payments from drug & device makers
What this record shows
This record is dominated by education: $15,000 of the $15,971 with a category attached, or 93.9%. Intuitive Surgical accounts for 95.0% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $12,648 and has fallen 74.1% since, to $3,273 in 2025.
Across 19 payments — averaging $840.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$15K
- Coloplast$261
- Valencia Technologies Corporation$155
- Myovant Sciences Inc.$118
- Medtronic$118
- Teleflex LLC$78
- plus $68 from 2 others
What the payments were for
- Travel & lodging$1551%
- Food & beverage$8165%
- Education$15,00094%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $15,174 |
| Coloplast | 3 | $261 |
| Valencia Technologies Corporation | 1 | $155 |
| Myovant Sciences Inc. | 1 | $118 |
| Medtronic | 1 | $118 |
| Teleflex LLC | 1 | $78 |
| Endo Pharmaceuticals Inc. | 2 | $37 |
| Johnson & Johnson | 1 | $31 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$15,000
- ALTIS$155
- eCoin Device Kit$155
- ORGOVYX$118
- INTERSTIM$118
How this compares
$15,971 in reported general payments places this provider in the 85th percentile of 53 transplant surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 22 | $23,507 |
| Methenamine Hippurate | 14 | $1,285 |
| Tamsulosin Hcl | 44 | $575 |
| Finasteride | 29 | $403 |
| Oxybutynin Chloride | 12 | $158 |
| Gentamicin Sulfate | 14 | $73 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 12 | $71 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other transplant surgery in Pensacola
- Matthew SandersPensacola$9K
- Alp DemiragPensacola$3K
- Rick StevensPensacola$106
- Scott SilvestryOrlando$661K
- Amy LuTampa$133K
- Eduardo AlsinaTampa$121K
- Kiran DhanireddyTampa$40K
- Vijay SubramanianTampa$22K
- Alfred TectorMiami$19K
- Nicole LooJacksonville$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.